Embolic Protection Devices Market Upcoming Trends, Growth, Analysis and Forecast - 2031

The global embolic protection devices market is estimated to record a substantial CAGR of 8.0% during the forecast period (2024-2031). Cardiovascular and neurovascular diseases are recognized as the leading cause of fatality and disability across the globe. Coronary artery disease (CAD) and peripheral artery disease (PAD) are the leading cardiovascular diseases globally. Besides, saphenous vein graft (SVG) failure is also common in patients following coronary artery bypass graft (CABG) surgery for treating CAD. In addition, about 250,000 patients have symptomatic severe AS. Such rising disease burden is influencing the higher uptake of embolic protection devices during various percutaneous cardiac procedures, including PCI, atherectomy, TAVR, CAS, to reduce the number of complications caused by debris being released into the bloodstream due to the procedures and causing blockages in smaller vessels by capturing and removing them. Therefore, the growing prevalence of various cardiovascular and neurovascular diseases are significantly contributing to the growth of the global embolic protection devices market.

Get Free Sample link @ https://www.omrglobal.com/request-sample/embolic-protection-devices-market

However, despite the success of embolic protection devices in many cardiovascular & peripheral and neurovascular applications, the clinical adoption of EPDs is still lagging compared to the expected penetration of the devices. In addition, the inadequate training of HCPs in LMICs regarding the latest surgical devices, infrastructure inadequacy, high procedural cost followed by poor reimbursement scenario are the major factors that can lead to the lesser uptake of modern embolic protection devices, which can limit the market growth.

Full report of Embolic Protection Devices Market available @ https://www.omrglobal.com/industry-reports/embolic-protection-devices-market

Market Coverage

Segment Covered- by Product, Application, and End-user
Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
Competitive Landscape- Abbott; Boston Scientific Corp.; Cardinal Health, Inc.; and Medtronic plc
Key questions addressed by the report

What is the market growth rate?
Which segment and region dominates the market in base year?
Which segment and region will project fastest growth in the market?
How COVID-19 impacted the market?
o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Embolic Protection Devices Market Report Segment

By Product

Filter Devices
Occlusion Devices
By Application

Cardiovascular & Peripheral
Neurovascular
By End-user

Ambulatory Surgery Centers
Freestanding CATH Labs
Hospitals
Specialty Cardiac Centers


Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.


For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/embolic-protection-devices-market

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.